Investors looking for groundbreaking opportunities in the healthcare sector might find COMPASS Pathways Plc (NASDAQ: CMPS) intriguing. Known for its pioneering work in psychedelic therapies, particularly psilocybin, COMPASS has placed..
Definitive Healthcare Corp. (NASDAQ: DH) is positioning itself as an intriguing opportunity for investors willing to navigate the complexities of the health information services sector. With its SaaS healthcare commercial..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology firm, is making waves in the healthcare sector with its promising pipeline dedicated to addressing unmet medical needs. As the company continues..
Tyra Biosciences, Inc. (NASDAQ: TYRA), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising developments in precision medicine. Specializing in fibroblast growth factor receptor (FGFR)..
Community Health Systems, Inc. (NYSE: CYH) presents a complex investment landscape for those interested in the healthcare sector, particularly within the medical care facilities industry. As the company continues to..
In the dynamic world of healthcare technology, Semler Scientific, Inc. (NASDAQ: SMLR) stands as a notable contender within the medical devices industry. Headquartered in Santa Clara, California, the company is..
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) stands out in the biotechnology industry with its innovative approach to tackling both childhood and adult diseases. With a market capitalization of $1.08 billion,..
Investors looking to diversify their portfolios with a stake in the burgeoning cannabis industry might find Tilray Brands, Inc. (TLRY) an intriguing prospect. As a prominent player in the healthcare..
Claritev Corporation (CTEV), a pivotal player in the healthcare sector, is drawing significant attention from investors with its compelling potential upside. With a market capitalization of $424.71 million, this U.S.-based..
Keros Therapeutics, Inc. (NASDAQ: KROS) presents a compelling investment opportunity within the biotechnology sector, marked by a notable 36.31% potential upside, according to current analyst ratings. As a clinical-stage biopharmaceutical..
AxoGen, Inc. (NASDAQ: AXGN), a prominent player in the healthcare sector specializing in medical devices, is currently capturing the attention of individual investors with its innovative approach to peripheral nerve..
Dianthus Therapeutics, Inc. (NASDAQ: DNTH) stands out in the biotechnology sector, capturing the attention of investors with a market cap of $2.01 billion and a promising 54.96% potential upside according..
Sonida Senior Living, Inc. (SNDA) stands as a notable player within the healthcare sector, specifically focusing on medical care facilities in the United States. With a current market capitalization of..
LifeMD, Inc. (NASDAQ: LFMD) is making waves in the healthcare sector as a direct-to-patient telehealth provider poised for significant growth. With its market cap standing at $133.34 million, LifeMD operates..
Upstream Bio, Inc. (NASDAQ: UPB) has captured the attention of investors within the biotechnology sector, primarily due to its promising pipeline and significant potential upside. As a clinical-stage biotechnology company,..
AMN Healthcare Services Inc (AMN) is a prominent player in the U.S. medical care facilities industry, providing a range of workforce solutions and staffing services to healthcare institutions. With a..
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its robust pipeline of engineered monoclonal antibodies. As Xencor focuses on treating a variety..
For investors with an appetite for high-risk and high-reward opportunities, Geron Corporation (NASDAQ: GERN) presents an intriguing case within the biotechnology sector. With its focus on oncology therapeutics, Geron is..
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands at the intersection of biotechnology and innovation, offering investors a glimpse into the future of cell programming. Despite a challenging market environment, the..
Kura Oncology, Inc. (NASDAQ: KURA) stands out in the biotech sector with its promising drug pipeline aimed at tackling some of the most challenging oncological diseases. As a clinical-stage biopharmaceutical..
